Literature DB >> 7445991

Studies in normal pregnancy. III. Fatty acid composition of serum phosphoglycerides and cholesterol esters.

A Skryten, P Johnson, A Gustafson.   

Abstract

Metabolic and hormonal influences on liver lipid synthesis are reflected in the relative fatty acid composition of serum lecithin. Thus, a successive decrease in essential fatty acids (EFA), i.e. n-6 fatty acids, during pregnancy would indicate an incipient EFA deficiency at the time of delivery. Furthermore, reciprocal changes in linoleic and arachidonic acids during the 1st trimester with an increase in arachidonic acid would suggest an enhancement of the Greenbeg Pathway (Pathway II) in lecithin synthesis presumably caused by estrogen influence. During the 2nd and 3rd trimester, reciprocal changes in lecithin content of palmitic and stearic acids are similar to changes appearing under cholestasis. It is furthermore suggested that variations in the utilization of linoleic acid in cholesterol esters (expressed as cholesterol ester 18:2/lecithin 18:2) might reflect changes in plasma cholesterol esterification by the enzyme lecithin-cholesterol-acyl-transferase (LCAT). Then, in late pregnancy, in relation to a subclinical cholestatic liver engagement, LCAT activity would increase as judged from this ratio as well as the increased linoleic acid in cholesterol esters.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7445991     DOI: 10.3109/00016348009154084

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  FA composition of cholesteryl esters and phospholipids in maternal plasma during pregnancy and at delivery and in cord plasma at birth.

Authors:  S R De Vriese; M Dhont; A B Christophe
Journal:  Lipids       Date:  2003-01       Impact factor: 1.880

2.  The fatty acid composition of serum lecithin after pregnancy complicated by pre-eclampsia.

Authors:  U Rosing; P Johnson; A Olund; G Samsioe
Journal:  Arch Gynecol       Date:  1984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.